{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:40:49Z","timestamp":1777977649555,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T00:00:00Z","timestamp":1173139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1007\/s10067-007-0594-1","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T07:36:02Z","timestamp":1173080162000},"page":"1969-1971","source":"Crossref","is-referenced-by-count":81,"title":["Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients"],"prefix":"10.1007","volume":"26","author":[{"given":"Kilian","family":"Verschueren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els","family":"Van Essche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Verschueren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerle","family":"Taelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene","family":"Westhovens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,3,6]]},"reference":[{"issue":"Suppl 1","key":"594_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.semarthrit.2005.01.003","volume":"34","author":"B Haraoui","year":"2005","unstructured":"Haraoui B (2005) Differentiating the efficacy of the tumor necrosis factor inhibitors. Semin Arthritis Rheum 34(Suppl 1):7\u201311","journal-title":"Semin Arthritis Rheum"},{"issue":"5 Suppl1","key":"594_CR2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semarthrit.2005.01.009","volume":"34","author":"RS Wallis","year":"2005","unstructured":"Wallis RS, Ehlers S (2005) Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab. Semin Arthritis Rheum 34(5 Suppl1):34\u201338","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"594_CR3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semarthrit.2006.02.001","volume":"36","author":"DE Furst","year":"2006","unstructured":"Furst DE, Wallis R, Broder M et al (2006) Tumor necrosis factor antagonists: different kinetics and\/or mechanisms of action may explain differences in the risk for developing granulomatous infection. Semin Arthritis Rheum 36(3):159\u2013167","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"594_CR4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.22238","volume":"55","author":"MA Gonzalez-Lopez","year":"2006","unstructured":"Gonzalez-Lopez MA, Blanco R, Gonzalez-Vela MC et al (2006) Development of sarcoidosis during etanercept therapy. Arthritis Rheum 55(5):817\u2013820","journal-title":"Arthritis Rheum"},{"issue":"5","key":"594_CR5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1398-9995.2005.00778.x","volume":"60","author":"H Nunes","year":"2005","unstructured":"Nunes H, Soler P, Valeyre D (2005) Pulmonary sarcoidosis. Allergy 60(5):565\u2013582","journal-title":"Allergy"},{"key":"594_CR6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-2796.2003.01074.x","volume":"253","author":"MW Ziegenhagen","year":"2003","unstructured":"Ziegenhagen MW, Muller-Quernheim J (2003) The cytokine network in sarcoidosis and its clinical relevance. J Intern Med 253:18\u201330","journal-title":"J Intern Med"},{"issue":"Suppl 2","key":"594_CR7","doi-asserted-by":"crossref","first-page":"ii79","DOI":"10.1136\/ard.2004.028498","volume":"63","author":"EC Keystone","year":"2004","unstructured":"Keystone EC (2004) The utility of tumour necrosis factor blockade in orphan diseases. Ann Rheum Dis 63(Suppl 2):ii79\u2013ii83","journal-title":"Ann Rheum Dis"},{"key":"594_CR8","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.127.3.1064","volume":"127","author":"JD Doty","year":"2005","unstructured":"Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127:1064\u20131071","journal-title":"Chest"},{"key":"594_CR9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1378\/chest.124.1.177","volume":"124","author":"JP Utz","year":"2003","unstructured":"Utz JP, Limper AH, Kalra S et al (2003) Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 124:177\u2013185","journal-title":"Chest"},{"issue":"3","key":"594_CR10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1378\/chest.95.3.604","volume":"95","author":"RF Kucera","year":"1989","unstructured":"Kucera RF (1989) A possible association of rheumatoid arthritis and sarcoidosis. Chest 95(3):604\u2013606","journal-title":"Chest"},{"key":"594_CR11","first-page":"40","volume":"74","author":"CA Dinarello","year":"2005","unstructured":"Dinarello CA (2005) Differences between anti-tumor necrosis factor-\u03b1 monoclonal antibodies and soluble TNF receptors in host defense impairment. J Rheumatol Suppl 74:40\u201347","journal-title":"J Rheumatol Suppl"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0594-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-007-0594-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0594-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T11:01:46Z","timestamp":1736852506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-007-0594-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,6]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["594"],"URL":"https:\/\/doi.org\/10.1007\/s10067-007-0594-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1116624.572675","asserted-by":"object"}]},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,6]]}}}